MLECW
Moolec Science S.A.
NASDAQ · Healthcare · Biotechnology · LU
$0.01
−3.92%Margins
Gross margin
34.2%
EBITDA margin
-20.7%
EBIT margin
-3.1%
Net margin
-33.4%
FCF margin
-9.0%
-3985.6%
Return on equity
-355.2%
Return on assets
-42.1%
Return on invested capital
10.44x
Asset turnover
-$24.5M
Cash from operations
$4.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025